Fernanda Masri

Head of Manufacturing Innovation • Cell and Gene Therapy Catapult

Fernanda is a Chemical Engineer with a Masters and PhD in Biochemical Engineering from University College London (UK). Early on, her research interest focused on small scale predictive tools for downstream processing for cell therapies.

Fernanda worked briefly in cryopreservation of human cells for therapies and then moved to the Centre for Commercialization of Regenerative Medicine (CCRM) as a Process Development Engineer. At CCRM, she worked on upstream scalable production of human pluripotent stem cells in suspension for cardiac differentiation to downstream processing of lentivirus using stable inducible cell lines.

She worked as a Technology Expert for Regenerative Medicine at Sartorius where she helped to accelerate development and manufacture of cell and gene therapies, making them more readily accessible to patients all over the world. She then worked as a Solutions Manager for iPSCs (also at Sartorius) where she was responsible for developing and implementing a global portfolio of tools and services specifically geared to iPSC customers. She joined the Cell and Gene Therapy Catapult (CGTC) in March 2021 as the Head of Commercial for the Manufacturing Centre in Stevenage, where her team supported collaborators and other UK CGT manufacturing developers with innovative solutions to cell and gene therapy specific manufacturing and supply chain bottlenecks. In her current position at CGTC, as head of manufacturing innovation BD, she looks to help deliver and implement innovative solutions across all CGTC innovation sites. She looks to help the industry achieve cost effective, robust and efficient manufacturing of ATMPs by easing the implementation of new solutions in the digital space as well as technologies in the GMP suite.

Also Speaking

Scott Gottesman

Vice President, Human Resources • AVROBIO

Shreenal Patel

Executive Vice President, Patient Supply • Achilles Therapeutics

John Balchunas

Workforce Director • The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2024.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.